Mountvector Bio SRL
The score of Mountvector Bio shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Accounts of the company itself (not consolidated).
Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Mountvector Bio's annual accounts
| 2025 | |
|---|---|
| Net result | −24,992 € |
| Equity | 174,355 € |
| Cash | 172,904 € |
| EBITDA | −24,837 € |
| Total assets | 180,416 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 28 Aug 2026
Mountvector Bio's financial analysis
- Solvency96.6%sector median: 34.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Mountvector Bio
Mountvector Bio's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1015.077.878
- VAT number
- BE1015077878
- Peppol
- Registered · 0208:1015077878 · as of 01 Nov 2026
- Legal form
- SRL
- Incorporated
- 14 Oct 2024
- Registered office
- 1348 Ottignies-Louvain-la-Neuve
- Latest accounts
- 2025 · filed on 28 Aug 2026
- Activity
- Manufacture of medicaments (NACE 21201)
Mountvector Bio (SRL) has been based in Ottignies-Louvain-la-Neuve since 2024, active in: manufacture of medicaments. For 2025, it reports a net loss of 24,992 € and equity of 174,355 €; its revenue is not published. Its solvency stands at 96.6%, above the median of its sector (34.4%).
Companies similar to Mountvector Bio
Companies in the same business, of comparable size and area, outside its group.
- LBS Manufacture of pharmaceutical preparations Ghent · balance sheet 291,800 €
- Parc Elisabeth Pharma Manufacture of pharmaceutical preparations Ganshoren · balance sheet 296,304 €
- Unda Manufacture of pharmaceutical preparations Aywaille · balance sheet 517,605 €
- 272BIO Manufacture of pharmaceutical preparations Ghent · balance sheet 709,601 €
- Phenix Property Manufacture of pharmaceutical preparations Hoogstraten · balance sheet €1.13m
- Eurandlab Manufacture of pharmaceutical preparations Charleroi · balance sheet 27,845 €
- Pledge Therapeutics Manufacture of basic pharmaceutical products Leuven · balance sheet 229,854 €
- Quantoom Bioservices Manufacture of basic pharmaceutical products Nivelles · balance sheet 59,035 €
Frequently asked questions about Mountvector Bio
What is the revenue of Mountvector Bio?
Mountvector Bio files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Mountvector Bio?
In Belgium, the VAT number is the company number prefixed with BE: BE1015077878 for Mountvector Bio, if the company is VAT-registered. Its company number (CBE) is 1015.077.878.
Where is the registered office of Mountvector Bio?
According to the CBE register, the registered office of Mountvector Bio is in 1348 Ottignies-Louvain-la-Neuve.
What is the equity of Mountvector Bio?
At the close of the 2025 financial year, the equity of Mountvector Bio amounts to 174,355 €, a solvency of 96.6% of total assets.
Who manages Mountvector Bio?
The register lists 2 active mandates at Mountvector Bio. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Mountvector Bio
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →